SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.06-2.9%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (6075)4/3/2002 12:55:36 PM
From: tuck  Read Replies (1) of 52153
 
Peter,

Or anyone. On similar lines, but somewhat OT in that it doesn't much relate to valuation . . .

I was wondering if another good time to buy is when a stock approaches lows, announces a shareholder rights plan, and goes down a bit more. Perhaps the second downdraft is a final wave of selling from nervous nellies who figure there must be something bad happening for such a measure to be taken. Today's case is CRGN, which I have again bought for a swing trade as it approaches lows after just such an announcement.

If I didn't have enough threads to look after already, I'd be tempted to create a "Shareholder Rights Hell" portfolio. Anyone want the job? Or, at least, has anyone noticed any patterns surrounding the above circumstances?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News